Tag : Full

Latest News

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2019 Global Net Product Revenues and Provides Additional Commercial Updates

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its preliminary* fourth quarter and full year 2019 global net product...
Latest News

Phreesia Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Newsemia
NEW YORK–(BUSINESS WIRE)–Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten secondary public offering of a...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy